Clinical Trials
Queen’s University leading cell therapy clinical trial to help improve outcomes in COVID-19 patients
Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients with acute respiratory failure.
This clinical trial, led by Professor Danny McAuley and Professor Cecilia O’Kane, both researchers from the...
Clinical Trials
Pfizer and BioNTech Aim to Start Testing Coronavirus Vaccines in Humans by Late April
Pfizer and BioNTech announced that they intend to advance multiple SARS-CoV-2 vaccine candidates into human clinical testing, with the first clinical trials potentially beginning by late April. The two companies began their collaboration focused on developing a vaccine for...
News
CirrusDx Laboratory receives emergency use authorisation from FDA for COVID-19 testing
CirrusDx validated and will commercialize the Allplex 2019-nCoV Assay, a real-time Reverse Transcriptase PCR test developed by Seegene, a South Korea-based global leader in multiplex molecular diagnostics.
Cirrus Dx, an infectious disease laboratory and diagnostics company, received Emergency Use Authorization...
IT & Data Management
CENTOGENE and Ubirch Create Secure Blockchain Solution for the Successful Fight Against COVID-19
CENTOGENE , a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, and the Cologne-based blockchain start-up Ubirch announced a joint solution for the successful fight...
News
Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing
Merck, a leading science and technology company, and The Jenner Institute announced that the Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
With patients enrolled for clinical trials for this vaccine, rapid...
News
Moderna Gets $483M BARDA Deal for COVID-19 Vaccine
Moderna, a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has entered an agreement for a commitment of up to $483 million from the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office...
News
Roche develops new serology test to detect COVID-19 antibodies
Roche announced the development and upcoming launch of its Elecsys® Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes the COVID-19 disease.
Antibody testing is central...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read